ARBOR PHARMACEUTICALS
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products... also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.
ARBOR PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2006-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.arborpharma.com
Total Employee:
501+
Status:
Closed
Contact:
6783342423
Email Addresses:
[email protected]
Total Funding:
40.44 M USD
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail GoDaddy DNS Microsoft Microsoft Azure Microsoft Azure US East Region AppRiver
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-20 | Xenoport | Xenoport acquired by Arbor Pharmaceuticals | 467 M USD |
Investors List
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Private Equity Round - Arbor Pharmaceuticals
Signet Healthcare Partners
Signet Healthcare Partners investment in Series B - Arbor Pharmaceuticals
ARCH Healthcare Fund
ARCH Healthcare Fund investment in Series B - Arbor Pharmaceuticals
JW Asset Management
JW Asset Management investment in Series B - Arbor Pharmaceuticals
Official Site Inspections
http://www.arborpharma.com
- Host name: hst02.sohoit.biz
- IP address: 184.154.14.86
- Location: Chicago United States
- Latitude: 41.8777
- Longitude: -87.6376
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60604
More informations about "Arbor Pharmaceuticals" on Search Engine
Arbor - Azurity Pharmaceuticals
Arbor Pharmaceuticals, LLC is a subsidiary of Azurity Pharmaceuticals, Inc. Click to learn more at Azurity.com or please wait to be automatically directed. GO NOW > PP-AZ …See details»
Arbor Pharmaceuticals - Crunchbase Company Profile & Funding
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage …See details»
Azurity Pharmaceuticals to Acquire and Merge with Arbor …
Aug 24, 2021 WOBURN, MA & ATLANTA, GA (August 24, 2021) – Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today …See details»
Azurity Pharmaceuticals Completes Acquisition of Arbor
The acquisition creates a leading company offering innovative, high-value products to meet the unique needs of patients with underserved conditions. With this acquisition, Arbor is …See details»
Azurity Pharmaceuticals to Acquire and Merge with …
Aug 24, 2021 WOBURN, Mass. & ATLANTA-- ( BUSINESS WIRE )--Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today announced they have entered into a definitive agreement …See details»
Azurity Pharma acquires Arbor Pharma | medthority.com
Oct 24, 2021 The acquisition creates a leading company offering innovative, high-value products to meet the unique needs of patients with underserved conditions. With this …See details»
Vertex and Arbor Establish New Partnership
Aug 24, 2021 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Arbor Biotechnologies ® (Arbor) today announced a new collaboration to enhance efforts in …See details»
Arbor Pharmaceuticals Company Profile 2024: Valuation, …
The company engages in the research, development, manufacturing and commercialization of prescription products for the cardiovascular, hospital, neuroscience and pediatric …See details»
Arbor Pharmaceuticals acquired by Azurity Pharmaceuticals
Acquired Organization: Arbor Pharmaceuticals Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common …See details»
Arbor Pharmaceuticals - Funding, Financials, Valuation & Investors
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.See details»
Azurity Pharmaceuticals to Acquire and Merge with Arbor …
Aug 24, 2021 Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) announced they have entered into a definitive agreement in which Azurity will …See details»
Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC
Aug 31, 2016 Laboratorios SALVAT is a privately owned pharmaceutical group closely identified with technological innovation and strongly committed to R&D. Founded in …See details»
Arbor Pharmaceuticals Announces Acquisition by Investment Group
RALEIGH, N.C., April 13 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company focused on pediatric medicine, announced today that an …See details»
Azurity Pharmaceuticals to Acquire and Merge with Arbor …
Aug 24, 2021 WOBURN, Mass. & ATLANTA– ( BUSINESS WIRE )–Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today …See details»
Ed Schutter - President & CEO @ Arbor Pharmaceuticals
Ed Schutter has 3 current jobs including President & CEO at Arbor Pharmaceuticals, President and Chief Operating Officer at Shionogi, and VP of Global Business …See details»
AR-36 - Drug Targets, Indications, Patents - Synapse
Jun 19, 2024 AR36 is a pharmaceutical-grade plant extract used to support cardiovascular health in traditional Chinese medicine. Studies suggest that AR36 may …See details»
AR 36 - AdisInsight - Springer
Aug 28, 2023 AR 36 is being developed by Arbor Pharmaceuticals (a subsidiary of Azurity Pharmaceuticals), in collaboration with a development partner, for the treatment ofSee details»
Arbor Pharmaceuticals - Contacts, Employees, Board Members, …
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.See details»
Arbor Biotechnologies Closes $215 Million Oversubscribed Series …
Nov 9, 2021 Arbor Biotechnologies ®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the completion of …See details»
Azurity Pharmaceuticals to Acquire and Merge with Arbor
Aug 24, 2021 Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today announced they have entered into a definitive agreement in which …See details»